Literature DB >> 28641974

Prostate Cancer Local Recurrence Detected With Both 18F-Fluciclovine and PSMA-targeted 18F-DCFPyL PET/CT.

Michael A Gorin1, Kenneth J Pienta2, Martin G Pomper3, Steven P Rowe4.   

Abstract

We present the case of a 79-year-old man with an elevated postprostatectomy prostate-specific antigen level who was sequentially imaged with positron emission tomography/computed tomography (PET/CT) using 18F-fluciclovine followed by PSMA-targeted 18F-DCFPyL. Although both imaging tests successfully identified the same pelvic recurrence, each radiotracer had its relative merits. This case highlights the differences between these two PET radiotracers, which are increasingly being used to image men with recurrent prostate cancer.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28641974     DOI: 10.1016/j.urology.2017.06.015

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  1 in total

Review 1.  Fluciclovine positron emission tomography in the setting of biochemical recurrence following local therapy of prostate cancer.

Authors:  Zachary A Glaser; Soroush Rais-Bahrami
Journal:  Transl Androl Urol       Date:  2018-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.